Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 40

1.

Huntington Disease: The Complexities of Making and Disclosing a Clinical Diagnosis After Premanifest Genetic Testing.

McCusker EA, Loy CT.

Tremor Other Hyperkinet Mov (N Y). 2017 Sep 6;7:467. doi: 10.7916/D8PK0TDD. eCollection 2017.

2.

Sex differences in the prevalence of genetic mutations in FTD and ALS: A meta-analysis.

Curtis AF, Masellis M, Hsiung GR, Moineddin R, Zhang K, Au B, Millett G, Mackenzie I, Rogaeva E, Tierney MC.

Neurology. 2017 Oct 10;89(15):1633-1642. doi: 10.1212/WNL.0000000000004494. Epub 2017 Sep 15. Review.

PMID:
28916533
3.

Neurodegenerative and psychiatric diseases among families with amyotrophic lateral sclerosis.

Longinetti E, Mariosa D, Larsson H, Ye W, Ingre C, Almqvist C, Lichtenstein P, Piehl F, Fang F.

Neurology. 2017 Aug 8;89(6):578-585. doi: 10.1212/WNL.0000000000004179. Epub 2017 Jul 12.

4.

Psychosis in behavioral variant frontotemporal dementia.

Gossink FT, Vijverberg EG, Krudop W, Scheltens P, Stek ML, Pijnenburg YA, Dols A.

Neuropsychiatr Dis Treat. 2017 Apr 13;13:1099-1106. doi: 10.2147/NDT.S127863. eCollection 2017.

5.

Frontotemporal Dementia.

Olney NT, Spina S, Miller BL.

Neurol Clin. 2017 May;35(2):339-374. doi: 10.1016/j.ncl.2017.01.008. Review.

PMID:
28410663
6.

Cerebrospinal fluid biomarker examination as a tool to discriminate behavioral variant frontotemporal dementia from primary psychiatric disorders.

Vijverberg EG, Dols A, Krudop WA, Del Campo Milan M, Kerssens CJ, Gossink F, Prins ND, Stek ML, Scheltens P, Teunissen CE, Pijnenburg YA.

Alzheimers Dement (Amst). 2017 Mar 2;7:99-106. doi: 10.1016/j.dadm.2017.01.009. eCollection 2017.

7.

Spatiotemporal progression of ubiquitin-proteasome system inhibition after status epilepticus suggests protective adaptation against hippocampal injury.

Engel T, Martinez-Villarreal J, Henke C, Jimenez-Mateos EM, Sanz-Rodriguez A, Alves M, Hernandez-Santana Y, Brennan GP, Kenny A, Campbell A, Lucas JJ, Henshall DC.

Mol Neurodegener. 2017 Feb 24;12(1):21. doi: 10.1186/s13024-017-0163-2.

8.

Neuropsychiatric Symptoms in Mild Cognitive Impairment.

Gallagher D, Fischer CE, Iaboni A.

Can J Psychiatry. 2017 Mar;62(3):161-169. doi: 10.1177/0706743716648296.

9.

Detecting and Managing Neuropsychiatric Symptoms in Dementia.

Iaboni A, Rapoport MJ.

Can J Psychiatry. 2017 Mar;62(3):158-160. doi: 10.1177/0706743716672409. No abstract available.

10.

Neuropsychological Testing in Pathologically Verified Alzheimer Disease and Frontotemporal Dementia: How Well Do the Uniform Data Set Measures Differentiate Between Diseases?

Ritter AR, Leger GC, Miller JB, Banks SJ.

Alzheimer Dis Assoc Disord. 2017 Jul-Sep;31(3):187-191. doi: 10.1097/WAD.0000000000000181.

PMID:
28005562
11.

Increased prevalence of autoimmune disease within C9 and FTD/MND cohorts: Completing the picture.

Miller ZA, Sturm VE, Camsari GB, Karydas A, Yokoyama JS, Grinberg LT, Boxer AL, Rosen HJ, Rankin KP, Gorno-Tempini ML, Coppola G, Geschwind DH, Rademakers R, Seeley WW, Graff-Radford NR, Miller BL.

Neurol Neuroimmunol Neuroinflamm. 2016 Oct 28;3(6):e301. eCollection 2016 Dec.

12.

Diagnostic utility of ASL-MRI and FDG-PET in the behavioral variant of FTD and AD.

Tosun D, Schuff N, Rabinovici GD, Ayakta N, Miller BL, Jagust W, Kramer J, Weiner MM, Rosen HJ.

Ann Clin Transl Neurol. 2016 Aug 30;3(10):740-751. eCollection 2016 Oct.

13.

Associations between cancer and Alzheimer's disease in a U.S. Medicare population.

Freedman DM, Wu J, Chen H, Kuncl RW, Enewold LR, Engels EA, Freedman ND, Pfeiffer RM.

Cancer Med. 2016 Oct;5(10):2965-2976. doi: 10.1002/cam4.850. Epub 2016 Sep 14.

14.

DAPHNE: A New Tool for the Assessment of the Behavioral Variant of Frontotemporal Dementia.

Boutoleau-Bretonnière C, Evrard C, Hardouin JB, Rocher L, Charriau T, Etcharry-Bouyx F, Auriacombe S, Richard-Mornas A, Lebert F, Pasquier F, Sauvaget A, Bulteau S, Vercelletto M, Derkinderen P, Bretonnière C, Thomas-Antérion C.

Dement Geriatr Cogn Dis Extra. 2015 Dec 18;5(3):503-16. doi: 10.1159/000440859. eCollection 2015 Sep-Dec.

15.

When a Little Knowledge Can Be Dangerous: False-Positive Diagnosis of Behavioral Variant Frontotemporal Dementia among Community Clinicians.

Shinagawa S, Catindig JA, Block NR, Miller BL, Rankin KP.

Dement Geriatr Cogn Disord. 2016;41(1-2):99-108. doi: 10.1159/000438454. Epub 2016 Jan 8.

16.

Neuroeconomic dissociation of semantic dementia and behavioural variant frontotemporal dementia.

Chiong W, Wood KA, Beagle AJ, Hsu M, Kayser AS, Miller BL, Kramer JH.

Brain. 2016 Feb;139(Pt 2):578-87. doi: 10.1093/brain/awv344. Epub 2015 Dec 14.

17.

The 5-HTTLPR variant in the serotonin transporter gene modifies degeneration of brain regions important for emotion in behavioral variant frontotemporal dementia.

Yokoyama JS, Bonham LW, Sturm VE, Adhimoolam B, Karydas A, Coppola G, Miller BL, Rankin KP.

Neuroimage Clin. 2015 Aug 18;9:283-90. doi: 10.1016/j.nicl.2015.07.017. eCollection 2015.

18.

Frontotemporal Dementia and Psychiatric Illness: Emerging Clinical and Biological Links in Gene Carriers.

Block NR, Sha SJ, Karydas AM, Fong JC, De May MG, Miller BL, Rosen HJ.

Am J Geriatr Psychiatry. 2016 Feb;24(2):107-16. doi: 10.1016/j.jagp.2015.04.007. Epub 2015 Jun 21.

19.

The behavioural variant frontotemporal dementia (bvFTD) syndrome in psychiatry.

Lanata SC, Miller BL.

J Neurol Neurosurg Psychiatry. 2016 May;87(5):501-11. doi: 10.1136/jnnp-2015-310697. Epub 2015 Jul 27. Review.

20.

Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairment.

Ismail Z, Smith EE, Geda Y, Sultzer D, Brodaty H, Smith G, Agüera-Ortiz L, Sweet R, Miller D, Lyketsos CG; ISTAART Neuropsychiatric Symptoms Professional Interest Area.

Alzheimers Dement. 2016 Feb;12(2):195-202. doi: 10.1016/j.jalz.2015.05.017. Epub 2015 Jun 18.

Supplemental Content

Support Center